Outlook Therapeutics Inc.
OTLK | NASDAQ
$0.70
+$0.01 (+2.00%)
Sep 22, 2026, 1:32 PM ET · Market open
TTM Period Ending | Q3 2026 Jun 29, 2026 | Q2 2026 Mar 30, 2026 | Q1 2026 Dec 30, 2025 | Q4 2025 Sep 29, 2025 | Q3 2025 Jun 29, 2025 | Q2 2025 Mar 30, 2025 | Q1 2025 Dec 30, 2024 | Q4 2024 Sep 29, 2024 | Q3 2024 Jun 29, 2024 | Q2 2024 Mar 30, 2024 | Q1 2024 Dec 30, 2023 | Q4 2023 Sep 29, 2023 | Q3 2023 Jun 29, 2023 | Q2 2023 Mar 30, 2023 | Q1 2023 Dec 30, 2022 | Q4 2022 Sep 29, 2022 | Q3 2022 Jun 29, 2022 | Q2 2022 Mar 30, 2022 | Q1 2022 Dec 30, 2021 | Q4 2021 Sep 29, 2021 | Q3 2021 Jun 29, 2021 | Q2 2021 Mar 30, 2021 | Q1 2021 Dec 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | -1.16M | 333.14K | 205.7K | 1.41M | 1.68M | 170.12K | 170.12K | 170.12K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 1.11M | 1.54M | 1.39M | 1.39M | 553.68K | 142.54K | 170.73K | 170.12K | 96.28K | 67.61K | 39.41K | 11.22K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 176.28K |
Gross Profit | -2.28M | -1.2M | -1.18M | 28.4K | 1.12M | 27.59K | -606 | n/a | -96.28K | -67.61K | -39.41K | -11.22K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -55.64M | -60.57M | -58.94M | -67.06M | -72.62M | -76.44M | -82.99M | -71.7M | -61.29M | -59.86M | -47.76M | -53.13M | -54.66M | -53.54M | -65.61M | -63.07M | -62.52M | -56.97M | -50.69M | -51.73M | -48.31M | -48.71M | -42.85M |
Interest Income | 3 | 3 | n/a | 48.88K | 288.83K | 693.43K | 693.43K | 833.22K | 899.09K | 890.03K | 1.08M | 889.15K | 583.33K | 187.79K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -62.64M | -62.51M | -104.41M | -63.98M | -43.44M | 21.12M | -46.81M | -75.36M | -94.05M | -159.13M | -51.5M | -58.98M | -60.33M | -57.2M | -70.25M | -66.05M | -65.11M | -59.77M | -53.17M | -53.16M | -49.68M | -43.77M | -36.36M |
Net Income | -61.12M | -60.96M | -102.86M | -62.42M | -43.44M | 21.12M | -46.81M | -75.37M | -94.05M | -159.13M | -51.5M | -58.98M | -60.34M | -57.2M | -70.25M | -66.05M | -65.11M | -59.77M | -53.17M | -53.16M | -49.68M | -40.5M | -33.09M |
Selling & General & Admin | 36M | 38.12M | 36.6M | 39.94M | 39.96M | 38.65M | 36.09M | 29.94M | 27.1M | 25.78M | 26.64M | 26.67M | 24.16M | 22.89M | 23.29M | 20.74M | 19.24M | 16.4M | 13.8M | 12.77M | 11.66M | 12.02M | 9.88M |
Research & Development | 17.36M | 21.25M | 21.15M | 27.18M | 33.72M | 37.79M | 46.89M | 41.76M | 34.18M | 34.08M | 21.12M | 26.45M | 30.5M | 30.65M | 42.32M | 42.33M | 43.28M | 40.57M | 36.88M | 38.96M | 36.65M | 36.59M | 32.44M |
Other Expenses | n/a | n/a | n/a | -29K | -29K | -29K | -29K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 53.36M | 59.37M | 57.76M | 67.09M | 73.66M | 76.41M | 82.96M | 71.7M | 61.29M | 59.86M | 47.76M | 53.13M | 54.66M | 53.54M | 65.61M | 63.07M | 62.52M | 56.97M | 50.69M | 51.73M | 48.31M | 40.22M | 33.94M |
Interest Expense | 264.16K | 313.51K | 332.01K | 332.01K | 67.85K | 18.5K | 3.08M | 3.08M | 3.08M | 3.08M | 303 | 2.45M | 2.81M | 3.17M | 3.58M | 1.49M | 1.4M | 1.3M | 1.13M | 936.13K | 685.98K | 872.73K | 1.32M |
Selling & Marketing Expenses | n/a | n/a | n/a | 298 | 298 | 298 | 298 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 54.47M | 60.91M | 59.14M | 68.48M | 74.13M | 76.44M | 82.99M | 71.7M | 61.29M | 59.86M | 47.76M | 53.13M | 54.66M | 53.54M | 65.61M | 63.07M | 62.52M | 56.97M | 50.69M | 51.73M | 48.31M | 48.61M | 42.32M |
Income Tax Expense | -1.51M | -1.55M | -1.55M | -1.55M | 2.8K | 2.8K | 2.8K | 2.8K | 2.8K | 2.8K | 2.8K | 2.8K | 3.6K | 3.6K | 2.8K | 2.8K | 2K | 2K | 2K | 2K | 2K | -3.27M | -3.27M |
Shares Outstanding (Basic) | 136.74M | 81.84M | 60.21M | 34.8M | 36.96M | 30.87M | 24.23M | 18.55M | 23.28M | 14.27M | 13.01M | 13.01M | 12.84M | 12.83M | 11.37M | 10.6M | 11.03M | 10.95M | 9.41M | 8.42M | 8.42M | 7.54M | 6.09M |
Shares Outstanding (Diluted) | 136.74M | 25.48M | 25.48M | 25.48M | 36.96M | 30.87M | 24.23M | 18.55M | 25.48M | 14.27M | 13.01M | 13.01M | 12.84M | 12.83M | 11.37M | 10.6M | 11.03M | 10.95M | 9.41M | 8.42M | 8.42M | 7.54M | 6.09M |
EPS (Basic) | -0.96 | -1.36 | -2.81 | -1.71 | -1.02 | 1.44 | -5.07 | -6.65 | -7.96 | -11.48 | -3.99 | -4.73 | -5.08 | -5.07 | -6.35 | -6.35 | -6.59 | -6.39 | -6.33 | -7.10 | -7.70 | -6.96 | -12.42 |
EPS (Diluted) | -1.22 | -1.62 | -2.95 | -1.85 | -1.02 | -1.36 | -7.87 | -9.45 | -10.76 | -11.48 | -3.99 | -4.73 | -5.08 | -5.07 | -6.35 | -6.35 | -6.59 | -6.39 | -6.39 | -7.16 | -7.76 | -7.02 | -12.42 |
EBITDA | -62.28M | -62.08M | -60.44M | -68.57M | -48.29M | 16.22M | 9.67M | 20.95M | -1.51M | -66.61M | -54.53M | -59.91M | -57.1M | -53.41M | -65.44M | -63.82M | -62.98M | -57.89M | -51.81M | -51.96M | -48.7M | -42.53M | -34.59M |
EBIT | -62.37M | -62.2M | -60.56M | -68.68M | -48.41M | 16.1M | 9.55M | 20.84M | -1.61M | -66.69M | -54.59M | -59.95M | -57.19M | -53.53M | -65.61M | -64.03M | -63.18M | -58.1M | -52.04M | -52.23M | -48.99M | -42.9M | -35.05M |
Depreciation & Amortization | 29.74K | 119.64K | 118.33K | 117.05K | 116.11K | 115.37K | 114.47K | 113.86K | 96.28K | 78.8K | 61.6K | 44.19K | 84.44K | 124.52K | 164.6K | 204.69K | 203.9K | 200.81K | 231.89K | 262.14K | 291.62K | 365.73K | 459.84K |
Add to Watchlist
Select watchlists to add or remove OTLK